16.000
−1,23%
2026-10-19
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -22.4% | +50.9% | 2 / 3 | -19.3% | -0.44 pp | -0.33 pp | +9.6% | 0.33 | 8.01 | 51,3 | −19,3% | 4,1 | −22,4% | 8.01 | 7.57 | +5,8% |
| Pts | 0 | 12 | 8 | 0 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 16.000 (close price on 2026-10-19)EPS (TTM): 1.997
Financial charts
1.Revenue & growth
VND bn51,3Q2/26
1.Revenue & growth
VND bn51,3Q2/26
2.Profit & growth
VND bn6,09Q2/26
3.Profit mix (Penman)
VND bn12,7Q2/26
4.Margins & cost structure
%25.0%Q2/26
5.Returns & cash cycle
% · days16.6%Q2/26
6.Earnings quality & cash
VND bn-17,5Q2/26
7.Asset structure
VND bn131Q2/26
8.Funding & debt health
VND bn · times131Q2/26
9.Revenue backlog
VND bn0,03Q2/26
10.Valuation
times · %6,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.414Q2/26
Adjusted EPS growth, latest quarter
14.4%
Average adjusted EPS growth, 3 quarters
63.1%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26